
Microbot Medical (MBOT) Stock Forecast & Price Target
Microbot Medical (MBOT) Analyst Ratings
Bulls say
Microbot Medical is attractive because LIBERTY addresses major adoption barriers in endovascular robotics by being fully disposable, compact, catheter-agnostic, and priced at $3,500-$4,000 per procedure, unlike capital-heavy systems that require large footprints and service infrastructure. Its clinical and commercial case is strengthened by 100% utilization and reorder rates, a 92% reduction in physician radiation exposure, 100% successful navigation in the pivotal study, and growing U.S. traction with 12 customer accounts and 10 sales territories as of 3Q26. With more than $60 million in cash, no debt, and a recurring-revenue model aimed at a ~2.5 million-procedure peripheral market with <1% robotic penetration, the company appears well funded to scale through the early commercialization phase.
Bears say
Microbot Medical is still in the earliest stages of monetizing LIBERTY, so its revenue base is narrow and highly dependent on a single platform that entered market release in April 2026 while adoption remains unproven. The latest results show deteriorating fundamentals, with gross profit loss widening to $1.0 mln, operating loss rising to $6.5 mln, and net loss at $5.8 mln, while operating expenses climbed 42% y/y to $5.5 mln on heavier commercialization and R&D spending. Its outlook is further pressured by lack of dedicated CMS reimbursement, slow hospital adoption of a single-use robotic system, reliance on third parties and suppliers, and ongoing royalty obligations of 1.5-3.0% of net sales to TRDF.
This aggregate rating is based on analysts' research of Microbot Medical and is not a guaranteed prediction by Public.com or investment advice.
Microbot Medical (MBOT) Analyst Forecast & Price Prediction
Start investing in Microbot Medical (MBOT)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Microbot Medical (MBOT) Forecast
Microbot Medical (MBOT) Analyst Forecast & Price Prediction
Start investing in Microbot Medical (MBOT)
Order type
Buy in
Order amount
Est. shares
0 shares